Professional Documents
Culture Documents
PII: S1734-1140(16)30297-3
DOI: http://dx.doi.org/doi:10.1016/j.pharep.2016.10.013
Reference: PHAREP 585
To appear in:
Please cite this article as: Md.Soriful Islam, James H.Segars, Mario Castellucci,
Pasquapina Ciarmela, Dietary phytochemicals for possible preventive
and therapeutic option of uterine fibroids: signaling pathways as target,
http://dx.doi.org/10.1016/j.pharep.2016.10.013
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1
FULL TITLE: Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids:
1
Department of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica delle
6205, Bangladesh;
3
Howard W. and Georgeanna Seegar Jones Division of Reproductive Sciences, Department of
Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
4
Department of Information Engineering, Università Politecnica delle Marche, Ancona 60131, Italy
*Corresponding author’s:
Faculty of Medicine, Università Politecnica delle Marche, via Tronto 10/a, 60020 Ancona, Italy
Faculty of Medicine, Università Politecnica delle Marche, via Tronto 10/a, 60020 Ancona, Italy
Abstract
A growing interest has emerged on dietary phytochemicals to control diverse pathological conditions.
Unfortunately, dietary phytochemical research in uterine fibroids is still under construction. Uterine
fibroids/leiomyomas are benign tumors developing from the myometrium of the uterus in premenopausal
women. They may occur in more than 70 % of women, and approximately 25 % of women show
clinically significant symptoms. These include heavy and prolonged menstrual bleeding, pelvic pressure
(urinary frequency, incontinence, and difficulty with urination), pelvic pain, pelvic mass, infertility, and
reproductive dysfunction. Due to lack of medical treatments surgery has been definitive choice for fibroid
management. Moreover, surgery negatively affects women’s quality of life, and its associated cost
appears to be expensive. The molecular mechanism of fibroids development and growth is not fully
elucidated. However, accumulated evidence shows that several signaling pathways, including Smad 2/3,
PI3K/AKT/mTOR, ERK 1/2 and β-catenin are involved in the leiomyoma pathogenesis, indicating that
they could serve as targets for prevention and/or treatment of this tumor. Therefore, in this review, we
discuss the involvement of signaling pathways in leiomyoma development and growth, and introduce
some potential dietary phytochemicals that could modulate those signaling pathways.
Keywords: Dietary phytochemicals, uterine fibroids, signaling pathways, growth factors, medical
treatment
3
Introduction
Uterine fibroids/leiomyomas are benign tumors developing from the myometrium of the uterus in
premenopausal women [1, 2]. They may occur in more than 70 % of women [3], and among these, about
20-50% of women are reported to produce clinically significant symptoms [4]. Leiomyoma associated
symptoms include: heavy and prolonged menstrual bleeding, pelvic pressure (urinary frequency,
incontinence, and difficulty with urination), pelvic pain, pelvic mass, infertility, and reproductive
dysfunction [5]. Surgery has been a definitive treatment of uterine fibroids. Moreover, surgery negatively
affects women’s quality of life, and its associated cost appears to be expensive. For example, in United
States, surgery associated cost of uterine fibroids management is approximately $5.9-34.4 billion annually
[6].
Unfortunately, the current medical treatments are limited and no effective prevention strategies
exist [7]. Moreover, the benefits of medical treatments are tempered by lack of efficacy or serious adverse
side effects. Poor understanding of the precise molecular mechanism of uterine fibroids development and
growth is may be the reason for the limitation of medical treatments. However, in recent years, significant
advances to uncover the molecular mechanisms of uterine fibroid development and growth have been
achieved [1, 8-11]. It is thought that uterine fibroids are monoclonal tumors, and approximately 40-50 %
contain karyotypic or cytogenetic abnormalities [12]. Notably, mediator complex subunit 12 (MED12)
Cell signaling is the transfer of information, by which cells perceive and respond to extracellular
stimuli including growth factors, neurotransmitters, and hormones. The signaling cascade starts with
binding of extracellular stimuli to a cell surface receptor. The receptor then activates series of downstream
signaling molecules in the cytoplasm that import signal to the nucleus for subsequent transcription of
target genes. The activation of several signaling pathways, such as Smad 2/3, phosphoinositide 3-kinase
(PI3K), extracellular-signal-regulated kinase 1/2 (ERK1/2), and β-catenin have been reported in
leiomyoma cells [8-11]. They regulate central events (such as inflammatory response, fibrosis,
4
proliferation and angiogenesis) of leiomyoma development and growth. Therefore, signaling pathways
could serve as excellent target for prevention and treatment of uterine fibroids.
Dietary phytochemicals are plant based chemical compounds with disease-preventive properties,
found in cereals, fruits, vegetables, legumes, herbs, spices, nuts, and beverages (such as tea, wine and
beer). They are known to exert therapeutic effects on multiple pathological conditions through modulating
diverse signaling pathways [14-16]. Accumulating evidences indicate that high intake of green vegetables
and fruit seem to have a protective role and associated with reduced risk of uterine fibroids of US and
Italian populations [17, 18]. This result supports the possible use of dietary phytochemicals for the
prevention and/treatment of uterine fibroids. However, phytochemical based research in uterine fibroids is
still under construction. For example, EGCG (epigallocatechin gallate), curcumin, resveratrol,
isoliquiritigenin and genistein are only few dietary phytochemicals that have been partially studied in
uterine leiomyoma [19-26]. They are mostly known for antiproliferative effects, however, their effects on
signaling pathways have not been addressed in leiomyoma cells except curcumin [21] and genistein [27].
Hence, there is much room for future research in the area of phytochemical based studies focusing on
signaling pathways as therapeutic target. Therefore, in this review, we discussed the role of signaling
pathways in leiomyoma development and growth, and introduced 14 dietary phytochemicals (Fig. 1) that
The father of medicine, Hippocrates, proclaimed that “Let food be thy medicine and medicine be thy
food” almost 25 centuries ago. However, the relationship between diet and health is yet to explore. The
human diet contains wide variety of plant-based foods that provide essential nutrients for the body.
Besides, plant-based foods possess huge variety of non-nutrient components that offer beneficiary effects
on health.
Accumulated epidemiologic studies indicate an inverse association between diet rich in fruits and
vegetables and the risk of cancers (such as colon, breast, and ovary) [28-30] and other diseases. The major
5
groups of health promoting dietary phytochemicals are phenolics [phenolic acid-gallic acid, stilbene-
phytosterols-sitosterol and stigmasterol [31]. For example, strawberry, a major source of anthocyanins
(i.e. pelargonidin-3-glucoside), flavonols (quercetin and kaempferol), ellagitannin (ellagic acid), flavanols
(catechins and procyanidins), and phenolic acid (caffeic acid), is known to exert therapeutic effects in
the prevention of diabetes, obesity, cancers, cardiovascular diseases, and neurodegenerative diseases [32].
It is thought that the health benefits of fruits and vegetables are the result of additive and synergistic
restrict tumorigenic steps: initiation, promotion, and progression [16]. In recent years, dietary
phytochemicals are being considered as a cost effective, acceptable and accessible approach for cancer
prevention and treatment. Therefore, dietary phytochemicals have been extensively investigated for their
multiple therapeutic effects as well as their safety, and low toxicity [34].
Accumulated evidence suggests that several signaling pathways, including Smad 2/3 (Fig.2A), PI3K
(Fig.2B), ERK 1/2 (Fig.3A), and β-catenin (Fig.3B) activated by growth factors, other peptide or
proteins, and hormones have been found in leiomyoma cells [8-11]. They regulate inflammatory response,
fibrosis, proliferation and angiogenesis that are important phenomenon for leiomyoma pathogenesis.
Since dietary phytochemicals may exert multiple therapeutic effects against diverse pathological
conditions, they could regulate leiomyoma development and growth through targeting signaling
pathways.
Smads are group of intracellular proteins that deliver extracellular signal to the nucleus induced by
transforming growth factor (TGF)-β superfamily members. Smads are classified into three different
inhibitory Smads (I-Smad). Smad1, Smad2, Smad3, Smad5 and Smad8 are known as R-Smad. R-Smads
interact with Co-Smad (Smad4) to promote downstream signaling [35]. In contrast, I-Smads (Smad6 and
In myometrial and leiomyoma cells, activin-A and TGF-β1 has been reported to induce Smad 2/3
signaling [9, 37]. They initiate signaling by binding to a type II receptor (ActRIIA or ActRIIB for activin-
A, and TGF-βRII for TGF-β), which recruits and phosphorylates a type I receptor [activin receptor-like
kinase (ALK)-4/ActRIB for activin-A, and ALK5/TGF-βRI for TGF-β). Next, activated type-I receptor
phosphorylates Smad2 and Smad3 that interact with Smad4 in the cytoplasm. This smad complex then
travels to the nucleus where interacts with other transcription factors and regulates transcription of target
Uterine leiomyoma demonstrated an elevated level of Smad3, Smad4 and phosphorylated Smad3
(p-Smad3) as well as TGF-βRI and TGF-βRII expression compared to normal counterpart [40]. TGF-β1
was reported to increase p-Smad3 induction in both myometrial and leiomyoma smooth muscle cells [37].
A number of studies reported that TGF-β1 can modulate inflammatory response, fibrosis, cell growth, and
apoptosis in myometrial and leiomyoma cells [41-45], which may be acquired , at least in part, through
activation of Smad 2/3 signaling [37]. The involvement of Smad 2/3 signaling in leiomyoma growth was
further documented by the observation that TGF-βRI kinase inhibitor, SB-525334 can block TGF-β
signaling in uterine leiomyoma cells, and significantly decreased tumor (leiomyoma) size, incidence and
multiplicity in Eker rat model [46]. Recently, we found that activin-A can induce phosphorylation of
Smad 2/3 in both primary myometrial and leiomyoma cells [9]. The ability of activin-A to increase
mRNA expression of fibronectin, collagen1A1, versican and vascular endothelial growth factor (VEGF)-
A in primary myometrial and/or leiomyoma cells [9, 47], demonstrating its profibrotic and angiogenic
role in this cell types. Ulipristal acetate is one of the most promising therapeutic options for leiomyoma
7
was found to decrease activin-A, follistatin, ActRIIB, and ALK4 mRNA expression in leiomyoma
cultured cells [47]. We also found that ulipristal acetate can block activin-A-induced mRNA expression
PI3K signaling
PI3Ks are a large family of intracellular signal transducers. Activation of PI3K signaling can occur
through G protein-coupled receptors and tyrosine kinase receptors [48]. Induction of PI3K signaling by
prolactin-releasing peptide (PrRP) and epidermal growth factor (EGF) has been reported in uterine
leiomyoma cells [8, 49]. Upon ligand binding, receptor complex becomes activated, and phosphorylates
PI3K at the cell membrane [48]. Phosphorylated PI3K converts PIP2 (phosphatidylinositol-4,5-
(PDK1) [51]. Next, phosphorylated AKT activates/inactivates series of downstream proteins to facilitate
translation of target proteins. mTOR (mammalian target of rapamycin) is a best studied downstream
substrate of AKT. There are two complexes of mTOR: TORC1-Raptor complex and TORC2-Rictor
complex. AKT activates mTOR through phosphorylating and inactivating TSC 1/2, which inhibits mTOR
through GTP-binding protein, Rheb (Ras homolog enriched in brain). Thus, Rheb accumulates and
activates the mTOR-raptor kinase complex. The activated TORC1-Raptor complex mediates
(4E-BP1) and p70S6Kinase, which subsequently promote synthesis of target proteins [52].
of uterine leiomyomas [8, 53-55]. Using in vivo and in vitro studies, Crabtree and co-workers confirmed
the upregulation of mTOR signaling pathway in both human and rat leiomyomas/tumors [53]. They found
that rapamycin analogue WAY-129327 decreased tumor size, incidence and multiplicity in Eker rats, and
inhibited mTOR signaling [53]. MK-2206, an AKT Inhibitor, was reported to reduce mTOR and p70S6K
phosphorylation and promote leiomyoma cell death [56]. Varghese’s group showed that PrRP promoted
8
PI3K/AKT/mTOR pathway through activation of GPR10, and increased primary leiomyoma cell
proliferation [8]. EGF has been reported to increase cell proliferation, and induce phosphorylation and
activation of EGFR and AKT in leiomyomal smooth muscle cells [49]. Involvement of PI3K/AKT
pathway in leiomyoma growth was further evidenced by the observation that inhibition of AKT using
API-59 (AKT inhibitor) decreased leiomyoma cell proliferation and cell viability, and promoted apoptosis
[57]. PTEN (phosphatase and tensin homolog) is a negative regulator of PI3K pathway. Uterine
ERK 1/2 is a cytoplasmic protein [58] that mediates signaling by EGF, platelet-derived growth factor
(PDGF), insulin-like growth factor (IGF)-I and TGF-β in myometrial and/or leiomyoma cells [10, 44,
59]. The signaling is initiated by binding of ligands to their corresponding receptors. Upon lingand
binding, receptor complex (homo- or heterodimers) become auto-and transphosphorylates and activates
that leads to the association of the receptor to cytoplasmic target proteins. Grb2 (growth factor receptor-
bound protein 2 adapter protein), a docking protein, that binds to the activated receptors either directly or
through Shc (src homology and collagen domain protein) [60]. Shc and Grb2 then recruit SOS (son of
sevenless), a guanine nucleotide exchange factor, which in turn activates Ras by exchanging GDP for
GTP. Ras is a small GTP-binding protein that recruits Raf and activates it. Activated Raf then
phosphorylates and activates MEK 1/2, which in turn phosphorylates and activates ERK 1/2 [61].
Activated ERK 1/2 moves to the nucleus where it regulates transcription of target genes [62, 63].
EGF has been reported to stimulate proliferation of leiomyomal smooth muscle cells through
activation of the EGFR-ERK1/2 pathway [49]. Stimulation of primary leiomyoma cells with EGF
markedly increased intracellular reactive oxygen species (ROS) production that mediates mitogen-
activated protein kinase (MAPK)3/MAPK1 (ERK 1/2) activation leading to cell proliferation [10]. The
role of EGF in leiomyoma growth was also supported by the observation that AG1478 and TKS050
(selective EGFR blockers) can block leiomyoma cell proliferation by inducing cell cycle arrest and
9
apoptosis [64, 65]. PDGF has been reported to activate ERK 1/2 signaling through intracellular ROS
production, and increase primary leiomyoma cell proliferation [10]. PDGF also increased collagen α1 (I)
mRNA expression in both myometrial and leiomyoma cells [66]. IGF-I was reported to increase uterine
leiomyoma cell proliferation by upregulating proliferating cell nuclear antigen (PCNA) expression and
downregulating apoptosis by upregulation of B-cell lymphoma-2 (Bcl-2) protein expression [59, 67]. The
stimulatory effect of IGF-I on leiomyoma growth was mediated, at least in part, by increasing
phosphorylation of IGF-IRβ, Shc and MAPKp44/42 (ERK1/2) [59]. TGF-β1 has been shown to regulate
inflammatory response, fibrosis, cell growth, and apoptosis in myometrial and leiomyoma cells [41-45], at
β-catenin signaling
β-catenin is the central component of wingless-type (WNT) signaling cascade. In the absence of WNT
‘destruction complex’ contains APC (adenomatous polyposis coli) and AXIN, which facilitate the
phosphorylation of β-catenin by CK1 (casein kinase 1) and GSK3 (glycogen synthase kinase 3) [68]. In
the presence of WNT ligands, WNT binds to the Frizzled receptors and several co-receptors such as LRP-
5/6 (lipoprotein receptor-related protein-5/6), RYK (receptor-like tyrosine kinase) or ROR2 (receptor
tyrosine kinase-like orphan receptor 2) [69] resulting in the inhibition of ‘destruction complex’ that
stabilize β-catenin in the cytoplasm. Next, stabilized β-catenin moves to the nucleus and interacts with
LEF (lymphoid enhancer factor)/TCF (T-cell factor) transcription factors to regulate transcription of
the pathogenesis of uterine fibroids [11, 71-73]. Tanwar and co-investigators developed a mouse model
that expresses constitutively activated β-catenin in uterine mesenchyme which gives rise to mesenchymal
tumors/leiomyoma-like tumors in the uterus [71]. The constitutive activation of β-catenin induced the
expression of TGF-β3 [71], which was shown to induce proliferation and extracellular matrix (ECM)
10
formation in human uterine leiomyoma cells [74]. The tumor suppressor gene, MED12, is mutated in ~
70% of uterine leiomyomas [13], which directly binds to β-catenin and regulates WNT signaling [75].
The expression of WNT4 was found to be elevated in leiomyoma with MED12 mutations versus those
without mutations [73]. An elegant experiment by Ono and co-workers uncovered a central role of the
WNT/β-catenin pathway induced by estrogen and progesterone in leiomyoma growth, which was
confirmed by the observation that blocking of WNT activity through inhibitor of β-Catenin and TCF4
inhibits the growth of leiomyoma-like tumors in immunodeficient mice [11]. They found that WNT11
and WNT16 were increased at mRNA levels in myometrial cells, which were remained constitutively
increased (not significant) in leiomyoma cells in response to estrogen and progesterone treatment [11]. In
addition, frizzled receptors, FZD1 and FZD7 were found to be significantly higher at mRNA levels in
leiomyoma side-population cells than in total leiomyoma cells or leiomyoma mature population cells [11].
This group also found that LRP5 and LRP6 (co-receptors for WNT) were expressed in leiomyoma side-
population cells and leiomyoma mature population cells. Furthermore, estrogen and progesterone were
found to selectively induce nuclear translocation of β-catenin and transcriptional activity of TCF and
AXIN2 in leiomyoma side-population cells cocultured with mature myometrial cells [11].
Here, we discuss 14 dietary phytochemicals that might target signaling pathways, including Smad 2/3
(Fig.2A), PI3K (Fig.2B), ERK 1/2 (Fig.3A), and β-catenin (Fig.3B) involved in cell proliferation,
angiogenesis, inflammation and fibrosis that are linked to uterine leiomyoma development and growth.
These dietary phytochemicals were chosen based on their ability to modulate signaling pathways in
Betulinic acid
Betulinic acid is a pentacyclic triterpene found in leaves of rosemary, and fruits of elephant apple.
Recently, Jin and co-workers reported that betulinic acid can inhibit 3-isobutyl-1-methylxanthine induced
11
melanogenesis via the downregulation of p-MEK, p-ERK and p-AKT in B16F10 cells [76]. Betulinic
acid may exert antiangiogenic activity in cultured endometrial adenocarcinoma cells through decreasing
expression of hypoxia-inducible factor (HIF)-1α, and VEGF [77]. In addition, betulinic acid was reported
translocation of nuclear factor-κB (NF-κB) in peripheral blood mononuclear cells [78]. The antifibrotic
effect of betulinic acid was documented by the observation that betulinic acid can attenuate liver hepatic
Butein
Butein is a type of chalcone derivative found in cashews. Khan and co-workers reported that butein can
inhibit prostate tumor growth in vivo through inhibition of PI3K/AKT pathway [80]. Butein also
suppressed breast cancer cell growth through downregulation of AKT phosphorylation [81]. Furthermore,
butein was reported to inhibit cell proliferation and clonogenecity of bladder cancer cells, through
phosphorylation of AKT, mTOR, and the major downstream effectors, p70S6K, 4E-BP1, and eIF4E in
endothelial progenitor cells [83]. Matrix metallopeptidase (MMP)-9 and VEGF are prominently involved
in the processes of tumor cell invasion and metastasis. It was shown that butein repressed tumor necrosis
factor (TNF)-α and phorbol-12-myristate-13-acetate induced expression of VEGF and MMP-9 via the
The anti-inflammatory effect of butein has been reported by several investigators [85-87]. Wang
and co-workers reported that butein suppressed adipocyte inflammation in 3T3-L1 cells by
mediators, such as IL-6, monocyte chemoattractant protein-1 (MCP-1), inducible nitric oxide synthase
(iNOS), nitric oxide (NO), NOS2 (nitric oxide synthase 2), CXCL (C-X-C motif chemokines)-1, and
CXCL-10) through partly suppression of NF-κB activation and MAPKs [ERK 1/2, c-Jun N-terminal
12
protein kinase (JNK), and p38 MAPK] signaling pathways [87]. Butein also decreased TNF-α-induced
monocyte cell adhesion to lung epithelial cells through inhibiting ROS generation and NF-κB activation
as well as the phosphorylation of MAPKs and AKT [85]. Furthermore, butein was reported to ameliorate
colitis in IL-10(-/-) mice, at least in part, by downregulation of IL-6, IL-1β, IFN-γ and MMP-9 as well as
The antifibrotic effect of butein has been documented by the observation that butein can inhibit
ethanol-induced activation of liver stellate cells through inhibition of TGF-β, p38 MAPK, and JNK
Capsaicin
Capsaicin, active component of chili peppers, is known to have tumor suppressive effects. Recently, Park
and co-workers reported that capsaicin can potentially inhibit the proliferation of human gastric cancer
cells and induce apoptosis, through decreasing the expression of p-ERK 1/2 [89]. Capsaicin was also
reported to exert anticancer effect on human colorectal cancer cells through modulating β-catenin
signaling pathway [90]. This compound promoted proteosomal- degradation of β-catenin, and suppressed
TCF-4 expression and disrupted the interaction between TCF-4 and β-catenin [90].
Capsaicin can induce antiangiogenic activity both in vitro and in vivo [91]. Treatment of human
multiple myeloma cells with capsaicin inhibited IL-6-induced STAT3 activation, and STAT3-regulated
gene products, such as cyclin D1, Bcl-2, Bcl-xL, survivin, and VEGF [92], suggesting its regulatory
function in proliferation, survival and angiogenesis, and apoptosis. In addition, capsaicin was reported to
increase degradation of HIF-1α, which is a key transcription factor in increasing VEGF transcription in
activation by decreasing cyclooxygenase (COX)-2, TGF-β1 and collagen expression [94], suggesting its
antifibrotic and antiinflammatory actions. Accordingly, capsaicin has been reported to suppress the
13
production of TNF-α [95], as well as prostaglandin E2 (PGE2) and NO production in macrophages via
Delphinidin
Delphinidin is a polyphenolic compound found in many pigmented fruits, including cranberries, Concord
grapes, and pomegranates. A recent study reported that delphinidin suppressed proliferation and migration
of human ovarian clear cell carcinoma cells through blocking phosphorylation of downstream targets of
PI3K (AKT and p70S6K) and MAPKs (ERK1/2 and JNK) [97]. Pal’s group demonstrated that
delphinidin can inhibit growth of non-small-cell lung cancer cells through inhibition of EGFR, VEGFR2
as well as PI3K/AKT and MAPKs pathways [98]. Delphinidin also inhibited in vivo tumor growth
endothelial cell proliferation as well as VEGFR2 signaling pathways, MAPKs (ERK1/2 and p38 MAPK)
and AKT activation in endothelial cells [100]. Lamy and co-workers reported that delphinidin can inhibit
smooth muscle cell migration as well as the differentiation and stabilization of endothelial cells, at least in
pathway [101].
In athymic nude mice implanted with human prostate cancer PC3 cells, delphinidin treatment
induced a significant inhibition of tumor growth, through downregulation of NF-κB expression [93].
Delphinidin also inhibited UVB-induced MMP-1 expression as well as ROS production and NOX activity
in primary cultured human dermal fibroblasts partly through suppression of MAPKs phosphorylation
[102].
Delphinidin has been reported to inhibit TGF-β1-induced expression of α-smooth muscle actin
(α-SMA), fibronectin, and collagen as well as activation of MAPKs and NF-κB in nasal polyp-derived
14
fibroblasts [103], suggesting its role in the regulation of myofibroblast differentiation and ECM
3,3′-Diindolylmethane
low pH environment. Several cruciferous vegetables, such as Brussels sprouts, cauliflower, cabbage,
broccoli, kale and turnips are known to be major sources of DIM. It has been shown that DIM can induce
antiproliferative and proapoptotic effects in oral squamous cell carcinoma cells and breast cancer cells,
through inactivation of NF-κB, AKT and MAPKs pathways [104, 105]. DIM also induced anti-
proliferative and pro-apoptotic effects in human cervical cancer cells through downregulating the
expression of p-AKT, PI3K, GSK-3β, p-PDK1 as well as p-c-Raf, p-ERK1/2 and p-p38 MAPK [106]. A
recent genome-wide transcriptome analysis showed that DIM can inhibit proliferation of colon cancer
cells through inactivation of Wnt/β-catenin signaling pathway [107]. DIM also suppressed the growth of
ovarian tumors in vitro and in vivo, at least in part, through reduction of EGFR, MEK, and ERK
phosphorylation [108].
Chang and co-workers found that DIM can inhibit VEGF-induced cell proliferation in human
umbilical vascular endothelial cells (HUVECs), at least in part, via downregulation of ERK1/2 and AKT
[109, 110]. DIM also inhibited invasion and angiogenesis in PDGF-D-overexpressing PC3 cells through
The anti-inflammatory effect of DIM was documented by the observation that DIM can inhibit
Zhang and co-investigators reported that DIM can attenuate hepatic fibrosis by inhibiting miR-21
expression, and TGF-β induced α-SMA and COL1A1 as well as p-Smad2/3 and total Smad2/3 expression
[113]. A recent study reported that DIM can attenuate TGF-β1-induced myofibroblastic transformation of
15
cardiac fibroblast through suppression of α-SMA, collagen I, collagen III, and connective tissue growth
Emodin
Emodin is an anthraquinone compound found in the root and rhizomes of Rhubarb. It has been shown that
emodin can inhibit tumor growth in orthotopic hepatocellular carcinoma mice model, at least in part, by
blocking of STAT3, JAK1/2 and AKT phosphorylation [115]. Emodin also downregulated the expression
of STAT3 regulated gene products, such as cyclin D1, Bcl-2, Bcl-xL, Mcl-1, survivin and VEGF in
HepG2 cells [115]. In human colorectal cancer cells, emodin downregulated the expression of β-catenin
and TCF7L2, as well as several downstream proteins, including cyclin D1, c-Myc, snail, vimentin, MMP-
2 and MMP-9 [116]. Emodin was also reported to repress TWIST1 (Twist-related protein 1)-induced
epithelial-mesenchymal transition (EMT) in head and neck squamous cell carcinoma FaDu cells through
inactivation of β-catenin and AKT signaling pathways [117]. A recent study reported that emodin can
inhibit the TGF-β-induced migration and invasion of human cervical cancer cells, partly through
Kaneshiro and co-investigators reported that emodin can inhibit endothelial cell proliferation,
migration, and tube formation through blocking ERK 1/2 phosphorylation [119], suggesting its
antiangiogenic properties.
vascular smooth muscle cells, through downregulating ROS generation, and phosphorylation of ERK1/2
and p38 MAPK [120], suggesting its antiinflammatory and antiatherosclerotic effects. Yin and co-
investigators reported that emodin can protect against LPS/D-galactosamine-induced liver injury in mice
through attenuating TNF-α production as well as p38 MAPK and NF-κB activation [121]. In addition,
emodin was reported to ameliorate LPS-induced mastitis in mice through reducing secretion and
expression of TNF-α, IL-1β and IL-6 via inactivating NF-κB and MAPKs pathways [122].
16
Emodin can exhibit antifibrotic effect on pancreatic fibrosis, at least in part, by reducing collagen
and TGF-β1 expression (Wang et al., 2007a). Lee and co-workers reported that emodin suppressed TNF-
α-induced MMP-1 expression in human dermal fibroblast cells through inhibition of the activator protein
1 (AP-1) and MAPKs (ERK 1/2 and JNK) pathways [123]. Emodin was also reported to suppress
glucose/IL-1β induced mesangial cell proliferation and ECM (fibronectin and/or collagen) production by
Ferulic acid
Ferulic acid is a ubiquitous polyphenolic compound in plant kingdom, found especially in artichokes,
eggplants and maize bran. Ambothi and co-investigators reported that ferulic acid can inhibit UVB-
radiation induced photocarcinogenesis through downregulation of VEGF, iNOS, mutant p53, Bcl-2
expressions and upregulation of the Bax expression [126], suggesting its antiinflammatory,
A recent report indicated that ferulic acid can inhibit fibroblast growth factor (FGF)1-induced
endothelial cell proliferation, migration and tube formation as well as microvessel sprouting of rat aortic
rings and angiogenesis [127]. The antiangiogenic effect of ferulic acid was mediated by inactivation of
FGFR1 and PI3K/PKB signaling [127]. Hou’s group reported that ferulic acid suppressed proliferation of
ECV304 endothelial cells and blocked the cell cycle in G0/G1 phase, and inhibited phosphorylation of
Recently, Xu and co-workers reported that ferulic acid can exhibit antifibrotic effects on hepatic
stellate cells through inhibiting ERK 1/2 and Smad 2/3 signaling pathways [129]. Particularly, this
compound reduced TGF-βRII, TGF-βRI and Smad4 mRNA and protein expression as well as Smad
transcriptional activity, and blocked ERK 1/2 phosphorylation in HSC-T6 cells [129]. Ferulic acid also
attenuated TGF-β1-induced renal cellular fibrosis in NRK-52E cells via inactivation of Smad 2/3
signaling pathway [130]. Furthermore, ferulic acid was reported to attenuate ischemia/reperfusion-
Fisetin
Fisetin is a flavonoid commonly present in apples, kiwis, strawberries, grapes, persimmons, onions and
cucumbers. Khan and co-workers reported that fisetin can inhibit growth of human non-small cell lung
cancer cells via suppression of PI3K/AKT/mTOR signaling [132]. In PC3 prostate cancer cells, fisetin
induced autophagic cell death through inhibition of mTOR signaling pathway [133].}. Particularly, fisetin
inhibited phosphorylation of mTOR kinase and downregulated the expression of Raptor, Rictor, PRAS40
and GβL as well as activated the mTOR repressor, TSC2 in this cell type [133]. Furthermore, fisetin was
reported to inhibit human laryngeal carcinoma cells of TU212 cell proliferation and induce apoptosis via
downregulating Raf, Ras, p-ERK1/2, PI3K, p-AKT, NF-κB and mTOR expression [134].
Fisetin has been reported to exert antiangiogenic effect by inhibiting VEGF-induced growth and
survival of HUVEC as well as capillary-like tube formation on Matrigel [135]. It also inhibited the
expression of eNOS (endothelial nitric oxide synthase), VEGF, iNOS, MMP-2 and MMP-9 in A549 and
13-acetate plus calcium ionophore A23187-stimulated gene expression and production of TNF-α, IL-1β,
IL-4, IL-6, and IL-8 via downregulation of MAPKs and NF-κB pathways [136]. Fisetin also reduced
secretion of IL-6 and TNF-α via inactivation of JNK and NF-κB in LPS-stimulated macrophage cells
[137]. Furthermore, fisetin was reported to inhibit IL-1β-induced cytokines (TNF-α, IL-6) and
chemokines (IL-8, MCP-1) in rheumatoid arthritic fibroblast-like synovial cells and in vivo models [138].
Kaempferol
Kaempferol is a flavonoid present in green tea, broccoli, apples, strawberries and green beans. A recent
study reported that kaempferol can suppress estrogen and triclosan stimulated breast cancer cell growth in
cellular and xenograft breast cancer models via downregulation of p-AKT and p-MEK1/2 expression
[139]. Kaempferol also inhibited proliferation of esophageal squamous cell carcinoma cells and induced
18
G0/G1 cell cycle arrest, and suppressed tumor growth in KYSE150 xenograft model via suppression of
EGFR and its downstream signaling pathways, ERK 1/2 and AKT [140]. Furthermore, kaempferol was
reported to suppress bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis
via downregulation of the p38 MAPK phosphorylation and c-Fos expression [141]. Kim and co-workers
reported that kaempferol inhibited PDGF-BB-induced rat aortic vascular smooth muscle cell proliferation,
at least in part, by downregulation of PDGFR-β phosphorylation and its downstream signal transduction
pathways, ERK1/2, AKT and PLC-γ1 phosphorylation and c-fos expression [142]. The ability of
kaempferol to downregulate IGF-I-induced phosphorylation of the IGF-IR and ERK 1/2 pathways in HT-
29 human colon cancer cells was reported by Lee and co-investigators [143].
angiogenesis and tumor growth, at least in part, by reducing VEGF and HIF-1α expression via
survival through downregulation of HIF-1 activity and p44/42 MAPK activation [145]. Furthermore,
kaempferol was reported to inhibit VEGF secretion, and in vitro angiogenesis, via downregulation of
Kaempferol exhibited a protective effect on LPS-induced acute lung injury in mice via
suppression of TNF-α, IL-1β and IL-6 production and MAPKs and NF-κB phosphorylation [147].
Kaempferol also attenuated myocardial ischemic injury via downregulation of TNF-α and IL-6
production as well as inhibition of MAPKs phosphorylation and NF-κB expression [148]. Yoon and co-
investigators reported that kaempferol can inhibit IL-1β-induced proliferation of rheumatoid arthritis
synovial fibroblasts and the expression of COX-2, PGE2 as well as MMP-1 and MMP-3, partly through
The antifibrotic effect of kaempferol was documented by the observation that kaempferol can
suppress collagen deposition, epithelial excrescency and goblet hyperplasia in the lung of ovalbumin-
Morin
Morin is a member of flavonols found in almonds that suppressed growth and invasion of the metastatic
breast cancer cell line MDA-MB 231 as well as cancer cell progression in xenograft mouse model, partly
suppression of goblet cell hyperplasia and collagen deposition and ovalbumin-induced TNF-α, IL-4, IL-
13, and MMP-9 via inactivating MAPKs pathway [152]. In human bronchial epithelial cells, morin also
inhibited TNF-α induced ROS generation and expression of eotaxin-1, MCP-1, and IL-8 [152].
Furthermore, morin was reported to suppress monosodium urate crystal-induced inflammation in RAW
264.7 macrophages through inhibition of expression and/or secretion of inflammatory mediators (TNF-α,
IL-1β, IL-6, MCP-1, NO, PEG2, iNOS and COX-2), VEGF expression, ROS generation, and NF-κB
activation [153].
Morin has been reported to ameliorate in vivo diethylnitrosamine-induced liver fibrosis in male
albino Wistar rat as well as inhibit proliferation of LX-2 cells (culture-activated human HSCs), partly
Naringin
Naringin is a flavanone glycoside found in grapefruit and related citrus species. Li and co-workers
reported that naringin can inhibit proliferation of triple-negative (ER-/PR-/HER2-) breast cancer cells
(MDA-MB-231, MDA-MB-468 and BT-549), through induction of apoptosis and G1 cycle arrest [155].
They also noticed that inactivation of β-catenin signaling pathway was responsible for this anticancer
effect [155]. Naringin also induced autophagy-mediated growth inhibition in AGS cancer cells by
downregulating the phosphorylation of PI3K and its activated downstream targets p-AKT and p-mTOR
Recently, Zhang and co-workers reported that naringin can prevent intestinal tumorigenesis in
Apc (Min/+) mouse model through suppression of cell proliferation, induction of apoptosis and inhibition
of expression and/or secretion of inflammatory mediators (Cox-2, NF-κB, TNF-α, PGE2 and IL-6) as
well as β-catenin expression and GSK-3β phosphorylation [157]. Naringin also inhibited growth of HeLa
cervical cancer cells and induces apoptosis, at least in part, by suppression of NF κB phosphorylation
and COX 2 expression [158]. Furthermore, naringin was reported to inhibit TNF-α-induced invasion and
migration of vascular smooth muscle cells as well as expression and/or secretion of MMP-9, IL-6 and IL-
The protective effects of naringin against paraquat-induced acute lung injury and pulmonary
fibrosis in mice have been reported, which was mediated primarily through downregulation of expression
of TGF-β1 and TNF-α as well as modulation of expression and ratios of MMP-9 and TIMP-1 [160].
Naringin also inhibited renal interstitial fibrosis and collagen formation partly through inhibiting
Pterostilbene
Several types of grapes and blueberries are major sources of pterostilbene. Pterostilbene has been reported
tumor formation possibly via inactivation of NF-κB and AP-1, and their upstream signaling pathways,
MAPKs, PI3K and AKT [162]. Paul’s group reported that pterostilbene can inhibit the growth of cultured
colon cancer HT-29 cells and induce apoptosis through downregulating TNF-α+IFN-γ+LPS-induced
iNOS and COX-2 expression via suppression of p38 MAPK signaling pathway [163]. Later study
reported that pterostilbene can reduce colon tumor multiplicity of non-invasive adenocarcinomas in rats
by inhibiting TNF-α, IL-1β and IL-4 expression via suppression of β-catenin and NF-κB signaling
pathways [164]. Chiou and co-workers reported that pterostilbene inhibited azoxymethane-induced
21
colorectal aberrant crypt foci and adenomas through upregulation of apoptosis and downregulation of
iNOS, COX-2, VEGF, cyclin D1, MMP-7, MMP-26, MMP-2, and MMP-9 expression and/or activity, at
least in part, via suppression of multiple signaling molecules, including p-GSK-3β, β-catenin, p-PI3K, p-
invasion, migration and metastasis of HepG2 cells by downregulation of angiogenic factors, such as
VEGF, EGF and EGFR expression, and their downstream signal transduction pathways, MAPKs,
Pterostilbene has been reported to inhibit high fat-induced atherosclerosis inflammation in mice
through inhibition of TNF-α, TGF-β1, IL-18, IL-6, IFN-γ, MCP-1 and IL-17 expression and/or secretion
via inactivation of NF-κB [167]. Pterostilbene also reduced the expression of TNF-α, IL-1 β, IL-6, COX-
2, MMP-2 and MMP-9, and ROS overproduction in hyperosmotic medium exposed human corneal
epithelial cells [168], suggesting its ability to protect corneal epithelial cells through antiinflammatory and
antioxidative effects.
It has been shown that pterostilbene inhibited dimethylnitrosamine-induced liver fibrosis in rats
[169]. The antifibrotic effect of pterostilbene in the dimethylnitrosamine-treated rats was mediated by
downregulation of α-SMA and MMP-2 expression as well as TGF-β1, and its signaling molecules, p-
Silibinin
Silibinin (also known as silybin) is a flavonolignan compound found artichokes. This compound can
evidenced by decreased cell proliferation [170, 171], and TNF-α-induced NF-κB activation, and thereby
NF-κB-regulated molecules, including Bcl-2, COX-2, iNOS, VEGF, HIF-1α and MMP9 [170-172]. This
effect was mediated, at least in part, by downregulation of β-catenin, IGF-1Rβ, p-GSK-3β, p-ERK 1/2
and p-AKT [170, 171]. Kim’s group reported that silibinin can suppress EGF-induced phosphorylation of
22
EGFR and ERK 1/2 in SKBR3 and BT474 breast cancer cells [173]. In nude mice model, silibinin also
attenuated the growth of melanoma xenograft tumors through inhibiting phosphorylation of MEK 1/2 and
Antiangiogenic effect of silibinin was documented by the observation that silibinin can inhibit
VEGF secretion and HIF-1α subunit accumulation in retinal pigmented epithelia cells through
downregulation of p-PI3K, p-AKT, p-mTOR and p70S6K [175]. In the rat model of age-related macular
degeneration, silibinin also prevented VEGF- and VEGF plus hypoxia-induced retinal oedema and
neovascularization [175]. Furthermore, silibinin was reported to inhibit human cervical and hepatoma
cancer cell growth by inhibiting HIF-1α protein synthesis and hypoxia-induced VEGF secretion via
suppression of the p-mTOR and its effectors, p70S6K and 4E-BP1 [176].
Silibinin has been reported to suppress LPS-induced neutrophilic airway inflammation, at least in
airway inflammation, and reduced the production of various cytokines (TNF-α, IL-1β, IL-4, IL-5, and IL-
13), partly via downregulation of NF-κB activity [178]. Furthermore, silibinin showed inhibitory effect on
TNF-α and COX-2 expression via inhibiting the PI3K/AKT signaling pathway, and NF-κB activation
[179].
Silibinin has been reported to attenuate cardiac hypertrophy and fibrosis by downregulating
EGFR-dependent ERK1/2 and PI3K/AKT, as well as activation of NF-κB and Smad 2/3 signaling
pathways [180]. Chen and colleagues reported that silibinin can inhibit myofibroblast transdifferentiation
in human tenon fibroblasts and reduce fibrosis in a rabbit trabeculectomy model [181]. Particularly,
collagen type I in human tenon fibroblasts through downregulation of p-Smad3 [181]. A study by Cho
and co-workers indicated that silibinin has the potential to prevent fibrotic skin changes by inducing the
downregulation of type I collagen expression in human skin fibroblasts, partly by the inhibition of TGF-
β1-induced p-Smad2 and p-Smad3 expression [182]. Silibinin exerts antiinflammatory and antifibrogenic
23
effects on human hepatic stellate cells by downregulation of human HSC cell proliferation, cell migration,
and de novo synthesis of collagen type I as well as IL-1β-induced synthesis of MCP-1 and IL-8 via
Thymoquinone
Thymoquinone is a bioactive component of black seed oil. It has been shown that thymoquinone can
induce cell cycle arrest and apoptosis in breast cancer cells through inhibition of PI3K/AKT pathway
[184, 185]. Particularly, thymoquinone reduced the phosphorylation of PTEN (inactivated form of
PTEN), PDK1 and AKT that resulted in the inhibition of 4E-BP1 and p70S6K [184]. In human
cholangiocarcinoma cells, thymoquinone induced inhibition of cell growth by inducing cell cycle arrest
and apoptosis through downregulation of PI3K/AKT and NF-κB pathways, and their regulated gene
products, including Bcl-2, COX-2, and VEGF [186]. Furthermore, thymoquinone was reported to inhibit
proliferation and invasion of human nonsmall-cell lung cancer cells via downregulation of ERK pathway
as confirmed by the reduced expression level of PCNA, cyclin D1, MMP-2 and MMP-9, and p-
ERK1/2[187].
Thymoquinone has been reported to prevent tumor angiogenesis in a mouse xenograft human
prostate cancer (PC3) model, and inhibited human prostate tumor growth through suppressing AKT and
ERK signaling pathways [188]. Thymoquinone also exhibited antiangiogenic effects on osteosarcoma in
vitro and in vivo through inactivating the NF-κB pathway as evidenced by downregulation of NF-κB
A recent study by Su and co-investigators reported that thymoquinone can inhibit inflammation
and neoangiogenesis induced by Ovalbumin in asthma mice by reducing IL-4 and IL-5 production, as
well as VEGF, p-VEGFR2, p-PI3K and p-AKT expression and tube information in HUVECs [190].
evidenced by decreased production of COX-2, iNOS, NO, and PGE2 as well as MMP-1, MMP-3, and
MMP-13 expression via inhibiting NF-κB activation and IκBα degradation as well as MAPKs pathway
24
activation [191]. Furthermore, thymoquinone was reported to inhibit TNF-α-induced IL-6 and IL-8
production in rheumatoid arthritis synovial fibroblasts by inhibiting JNK and p38 MAPK signaling
pathways [192].
Thymoquinone has been reported to attenuate liver fibrosis by reducing α-SMA, collagen1A1,
collagen3A1, TIMP-1, L-1α, IL-1β and IL-18 levels, at least in part, via inactivating PI3K and TLR4
signaling pathways [193-195]. Thymoquinone can also block lung injury and fibrosis in rats induced by
bleomycin/paraquat herbicide through downregulation of TGF-β1, α-SMA, collagen 1A1 and collagen
4A1, and inhibition of oxidative stress and NF-κB activation [196, 197].
The precise molecular mechanisms of leiomyoma pathogenesis are not well understood. However,
accumulating evidences suggest that several signaling pathways, such as Smad 2/3, PI3K, ERK1/2 and β-
catenin are involved in regulating central events (such as inflammatory response, fibrosis, proliferation
and angiogenesis) of leiomyoma development and growth. Thus, they may act as excellent target for
possible prevention and treatment of uterine fibroids. Here, we introduced 14 dietary phytochemicals
(betulinic acid, butein, capsaicin, delphinidin, 3,3'-diindolylmethane, emodin, ferulic acid, fisetin,
kaempferol, morin, naringin, pterostilbene, silibinin and thymoquinone) that could potentially be used as
therapeutic and/or preventive compounds for uterine leiomyoma (Fig. 1). These dietary phytochemicals
have shown their ability to regulate major tumor initiating and promoting events such as, inflammation,
fibrosis, proliferation and angiogenesis in different experimental conditions through regulating several
signaling pathways, including Smad 2/3, PI3K, ERK 1/2 and β-catenin. Future research may include these
dietary phytochemicals to check their ability to modulate signaling pathways in uterine fibroids. Dietary
phytochemicals are not limited to these 14 compounds. Other potential dietary phytochemicals that have
not yet been tested could be included for future research in uterine fibroids.
25
Funding body
This work was supported by a grant from the “Fondazione Cassa di Risparmio di Fabriano e
Conflict of interest
None
References
[1] Islam MS, Protic O, Stortoni P, Grechi G, Lamanna P, Petraglia F, et al. Complex networks of
[3] Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine
leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-7.
[4] Buttram Jr VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil
Steril. 1981;36:433-45.
[5] Sabry M, Al-Hendy A. Innovative oral treatments of uterine leiomyoma. Obstet Gynecol Int.
2012;2012:943635.
[6] Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost
of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211. e1-. e9.
[7] Islam MS, Protic O, Toti P, Giannubilo SR, Tranquilli AL, Petraglia F, et al. Uterine leiomyoma:
available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab.
2013;98:921–34.
[8] Varghese BV, Koohestani F, McWilliams M, Colvin A, Gunewardena S, Kinsey WH, et al. Loss of
the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and
activates mammalian target of rapamycin pathway. Proc Natl Acad Sci U S A. 2013;110:2187-92.
26
[9] Islam MS, Catherino WH, Protic O, Janjusevic M, Gray PC, Giannubilo SR, et al. Role of activin-A
and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J Clin
[10] Mesquita FS, Dyer SN, Heinrich DA, Bulun SE, Marsh EE, Nowak RA. Reactive oxygen species
mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol
Reprod. 2010;82:341-51.
[11] Ono M, Yin P, Navarro A, Moravek MB, Coon JS, Druschitz SA, et al. Paracrine activation of
WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U
S A. 2013;110:17053-8.
[12] Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors:
[13] Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al. MED12, the mediator
complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334:252-5.
[14] Kim M-K, Kim K, Han JY, Lim JM, Song YS. Modulation of inflammatory signaling pathways by
[15] Vidya Priyadarsini R, Nagini S. Cancer chemoprevention by dietary phytochemicals: promises and
[16] Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3:768-80.
[17] Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine
[18] Wise LA, Radin RG, Palmer JR, Kumanyika SK, Boggs DA, Rosenberg L. Intake of fruit,
vegetables, and carotenoids in relation to risk of uterine leiomyomata. Am J Clin Nutr. 2011;94:1620-31.
Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil
Steril. 2010;94:1887-93.
27
Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet
[21] Malik M, Mendoza M, Payson M, Catherino WH. Curcumin, a nutritional supplement with
antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil
Steril. 2009;91:2177-84.
[22] Catherino WH, Parrott E, Segars J. Proceedings from the National Institute of Child Health and
Human Development Conference on the Uterine Fibroid Research Update Workshop. Fertil Steril.
2011;95:9-12.
[23] Wu C-H, Shieh T-M, Wei L-H, Cheng T-F, Chen H-Y, Huang T-C, et al. Resveratrol inhibits
proliferation of myometrial and leiomyoma cells and decreases extracellular matrix-associated protein
[24] Kim D, Ramachandran S, Baek S, Kwon SH, Kwon KY, Cha SD, et al. Induction of growth
inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci. 2008;15:552-
8.
[25] Moore AB, Castro L, Yu L, Zheng X, Di X, Sifre MI, et al. Stimulatory and inhibitory effects of
genistein on human uterine leiomyoma cell proliferation are influenced by the concentration. Hum
Reprod. 2007;22:2623-31.
[26] Islam MS, Akhtar MM, Ciavattini A, Giannubilo SR, Protic O, Janjusevic M, et al. Use of dietary
Promising options for prevention and treatment of uterine fibroids? Mol Nutr Food Res. 2014;58:1667-
84.
[27] Di X, Andrews DMK, Tucker CJ, Yu L, Moore AB, Zheng X, et al. A high concentration of
genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma
[28] Magalhaes B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and
[29] Aune D, Chan DSM, Vieira AR, Rosenblatt DAN, Vieira R, Greenwood DC, et al. Fruits, vegetables
and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res
Treat. 2012;134:479-93.
[30] Paxton RJ, Garcia-Prieto C, Berglund M, Hernandez M, Hajek RA, Handy B, et al. A randomized
parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012;124:410-6.
[31] Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr. 2013;4:384S-
92S.
[32] Giampieri F, Forbes-Hernandez TY, Gasparrini M, Alvarez-Suarez JM, Afrin S, Bompadre S, et al.
Strawberry as a health promoter: an evidence based review. Food & function. 2015;6:1386-98.
[33] Liu RH. Dietary bioactive compounds and their health implications. J Food Sci. 2013;78:A18-A25.
[34] Amin ARMR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural
[35] Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the
[36] Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S. Promoting bone morphogenetic protein
[37] Xu J, Luo X, Chegini N. Differential expression, regulation, and induction of Smads, transforming
growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and
[38] Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through
[39] Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell.
2003;113:685-700.
29
[40] Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta
receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue
[41] Arici A, Sozen I. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of
2003;188:76-83.
[42] Luo X, Ding L, Xu J, Chegini N. Gene expression profiling of leiomyoma and myometrial smooth
[43] Luo X, Ding L, Chegini N. CCNs, fibulin-1C and S100A4 expression in leiomyoma and
myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and
[44] Ding L, Xu J, Luo X, Chegini N. Gonadotropin releasing hormone and transforming growth factor
beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate
fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and
[45] Levens E, Luo X, Ding L, Williams RS, Chegini N. Fibromodulin is expressed in leiomyoma and
myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through
[46] Laping NJ, Everitt JI, Frazier KS, Burgert M, Portis MJ, Cadacio C, et al. Tumor-specific efficacy of
transforming growth factor-beta RI inhibition in Eker rats. Clin Cancer Res. 2007;13:3087-99.
[47] Ciarmela P, Carrarelli P, Islam MS, Janjusevic M, Zupi E, Tosti C, et al. Ulipristal acetate modulates
the expression and functions of activin A in leiomyoma cells. Reprod Sci. 2014;21:1120-5.
[48] Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of
[49] Ren Y, Yin H, Tian R, Cui L, Zhu Y, Lin W, et al. Different effects of epidermal growth factor on
smooth muscle cells derived from human myometrium and from leiomyoma. Fertil Steril. 2011;96:1015-
20.
[50] Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008;27:5486-96.
[51] Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PRJ, Reese CB, et al. Characterization of a
3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.
[52] Richardson CJ, Schalm SS, Blenis J. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev
Biol. 2004;15:147-59.
[53] Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, et al. Comparison of
human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin
[54] Karra L, Shushan A, Ben-Meir A, Rojansky N, Klein BY, Shveiky D, et al. Changes related to
[55] Kovacs KA, Lengyel F, Vértes Z, Környei JL, Gőcze PM, Sumegi B, et al. Phosphorylation of PTEN
(phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human
[56] Sefton EC, Qiang W, Serna V, Kurita T, Wei J-J, Chakravarti D, et al. MK-2206, an AKT Inhibitor,
promotes caspase-independent cell death and inhibits leiomyoma growth. Endocrinology. 2013;154:4046-
57.
[57] Hoekstra AV, Sefton EC, Berry E, Lu Z, Hardt J, Marsh E, et al. Progestins activate the AKT
pathway in leiomyoma cells and promote survival. J Clin Endocrinol Metab. 2009;94:1768-74.
[58] Boulton TG, Nye SH, Robbins DJ, Ip NY, Radzlejewska E, Morgenbesser SD, et al. ERKs: a family
of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin
[59] Yu L, Saile K, Swartz CD, He H, Zheng X, Kissling GE, et al. Differential expression of receptor
tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol Med.
2008;14:264-75.
[61] Avruch J, Zhang X-f, Kyriakis JM. Raf meets Ras: completing the framework of a signal
[62] Adachi M, Fukuda M, Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase
[63] Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse
[64] Shushan A, Rojansky N, Laufer N, Klein BY, Shlomai Z, Levitzki R, et al. The AG1478 tyrosine
kinase inhibitor is an effective suppressor of leiomyoma cell growth. Hum Reprod. 2004;19:1957-67.
[65] Shushan A, Ben-Bassat H, Mishani E, Laufer N, Klein BY, Rojansky N. Inhibition of leiomyoma
cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril.
2007;87:127-35.
[66] Liang M, Wang H, Zhang Y, Lu S, Wang Z. Expression and functional analysis of platelet-derived
[67] Gao Z, Matsuo H, Wang Y, Nakago S, Maruo T. Up-regulation by IGF-I of proliferating cell nuclear
antigen and Bcl-2 protein expression in human uterine leiomyoma cells. J Clin Endocrinol Metab.
2001;86:5593-9.
[68] Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and β-catenin signalling: diseases and
[69] Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev
Biol. 2004;20:781-810.
[70] Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006;25:7461-
8.
32
[71] Tanwar PS, Lee H-J, Zhang L, Zukerberg LR, Taketo MM, Rueda BR, et al. Constitutive activation
of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in
[72] Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J. Conditional deletion of
beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the
[73] Markowski DN, Bartnitzke S, Löning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations
[74] Arici A, Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where
[75] Kim S, Xu X, Hecht A, Boyer TG. Mediator is a transducer of Wnt/β-catenin signaling. J Biol Chem.
2006;281:14066-75.
[76] Jin K-S, Oh YN, Hyun SK, Kwon HJ, Kim BW. Betulinic acid isolated from Vitis amurensis root
[77] Karna E, Szoka L, Palka JA. Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha
and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol Cell Biochem.
2010;340:15-20.
[78] Viji V, Shobha B, Kavitha SK, Ratheesh M, Kripa K, Helen A. Betulinic acid isolated from Bacopa
2010;10:843-9.
attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS),
2011;280:152-63.
33
[80] Khan N, Adhami VM, Afaq F, Mukhtar H. Butein induces apoptosis and inhibits prostate tumor
[81] Cho SG, Woo SM, Ko SG. Butein suppresses breast cancer growth by reducing a production of
[82] Zhang L, Chen W, Li X. A novel anticancer effect of butein: Inhibition of invasion through the
ERK1/2 and NF-B signaling pathways in bladder cancer cells. FEBS Lett. 2008;582:1821-8.
[83] Chung C-H, Chang C-H, Chen S-S, Wang H-H, Yen J-Y, Hsiao C-J, et al. Butein inhibits
angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway. Evid
[84] Moon D-O, Choi YH, Moon S-K, Kim W-J, Kim G-Y. Butein suppresses the expression of nuclear
factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate
[85] Jang JH, Yang ES, Min K-J, Kwon TK. Inhibitory effect of butein on tumor necrosis factor-α-
induced expression of cell adhesion molecules in human lung epithelial cells via inhibition of reactive
oxygen species generation, NF-κB activation and Akt phosphorylation. Int J Mol Med. 2012;30:1357-64.
[86] Lee SD, Choe JW, Lee BJ, Kang MH, Joo MK, Kim JH, et al. Butein effects in colitis and
[87] Wang Z, Lee Y, Eun JS, Bae EJ. Inhibition of adipocyte inflammation and macrophage chemotaxis
ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways
[89] Park S-Y, Kim J-Y, Lee S-M, Jun C-H, Cho S-B, Park C-H, et al. Capsaicin induces apoptosis and
modulates MAPK signaling in human gastric cancer cells. Mol Med Rep. 2014;9:499-502.
34
[90] Lee S-H, Richardson RL, Dashwood RH, Baek SJ. Capsaicin represses transcriptional activity of β-
[91] Min J-K, Han K-Y, Kim E-C, Kim Y-M, Lee S-W, Kim O-H, et al. Capsaicin inhibits in vitro and in
[92] Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, et al. Capsaicin is a novel
blocker of constitutive and interleukin-6 -inducible STAT3 activation. Clin Cancer Res. 2007;13:3024-
32.
induced activation of p53-SMAR1 auto-regulatory loop down-regulates VEGF in non-small cell lung
[94] Bitencourt S, de Mesquita FC, Caberlon E, da Silva GV, Basso BS, Ferreira GA, et al. Capsaicin
induces de-differentiation of activated hepatic stellate cell. Biochem Cell Biol. 2012;90:683-90.
[95] Park J-Y, Kawada T, Han I-S, Kim B-S, Goto T, Takahashi N, et al. Capsaicin inhibits the
production of tumor necrosis factor α by LPS-stimulated murine macrophages, RAW 264.7: a PPARγ
[96] Kim C-S, Kawada T, Kim B-S, Han I-S, Choe S-Y, Kurata T, et al. Capsaicin exhibits anti-
Signal. 2003;15:299-306.
[97] Lim W, Jeong W, Song G. Delphinidin suppresses proliferation and migration of human ovarian
clear cell carcinoma cells through blocking AKT and ERK1/2 MAPK signaling pathways. Mol Cell
Endocrinol. 2016;422:172-81.
[98] Pal HC, Sharma S, Strickland LR, Agarwal J, Athar M, Elmets CA, et al. Delphinidin reduces cell
proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2
[99] Keravis Trs, Favot L, Abusnina AA, Anton A, Justiniano Hln, Soleti R, et al. Delphinidin Inhibits
Tumor Growth by Acting on VEGF Signalling in Endothelial Cells. PloS one. 2015;10:e0145291.
35
[100] Duluc L, Jacques C, Soleti R, Andriantsitohaina R, Simard G. Delphinidin inhibits VEGF induced-
mitochondrial biogenesis and Akt activation in endothelial cells. Int J Biochem Cell Biol. 2014;53:9-14.
[101] Lamy S, Beaulieu E, Labbe D, Bedard V, Moghrabi A, Barrette S, et al. Delphinidin, a dietary
Carcinogenesis. 2008;29:1033-41.
[102] Lim T-G, Jung SK, Kim J-e, Kim Y, Lee HJ, Jang TS, et al. NADPH oxidase is a novel target of
delphinidin for the inhibition of UVB-induced MMP-1 expression in human dermal fibroblasts. Exp
Dermatol. 2013;22:428-30.
[103] Cho J-S, Kang J-H, Shin J-M, Park I-H, Lee H-M. Inhibitory effect of delphinidin on extracellular
matrix production via the MAPK/NF-κB pathway in nasal polyp-derived fibroblasts. Allergy Asthma
[104] Weng JR, Bai LY, Chiu CF, Wang YC, Tsai MH. The dietary phytochemical 3,3'-diindolylmethane
induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-B, MAPK,
[105] Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-kB contributes to 3,3'-
[107] Leem S-H, Li XJ, Park MH, Park BH, Kim SM. Genome-wide transcriptome analysis reveals
Oncol. 2015;47:918-26.
[108] Kandala PK, Wright SE, Srivastava SK. Blocking epidermal growth factor receptor activation by 3,
3′-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo. J Pharmacol Exp Ther.
2012;341:24-32.
[109] Chang X, Firestone GL, Bjeldanes LF. Inhibition of growth factor-induced Ras signaling in
[110] Kunimasa K, Kobayashi T, Kaji K, Ohta T. Antiangiogenic effects of indole-3-carbinol and 3,3'-
diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming
[111] Kong D, Banerjee S, Huang W, Li Y, Wang Z, Kim H-RC, et al. Mammalian target of rapamycin
[112] Kim HW, Kim J, Kim J, Lee S, Choi B-R, Han J-S, et al. 3, 3′-Diindolylmethane inhibits
2014;137:158-67.
[113] Zhang Z, Gao Z, Hu W, Yin S, Wang C, Zang Y, et al. 3, 3' Diindolylmethane ameliorates
myofibroblast differentiation in neonatal rat cardiac fibroblasts. Int J Clin Exp Pathol. 2015;8:5121-8.
[115] Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, et al. Emodin inhibits
growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of
[116] Pooja T, Karunagaran D. Emodin suppresses Wnt signaling in human colorectal cancer cells
[117] Way T-D, Huang J-T, Chou C-H, Huang C-H, Yang M-H, Ho C-T. Emodin represses TWIST1-
induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting
[118] Thacker PC, Karunagaran D. Curcumin and emodin down-regulate TGF-β signaling pathway in
[119] Kaneshiro T, Morioka T, Inamine M, Kinjo T, Arakaki J, Chiba I, et al. Anthraquinone derivative
generation in vascular smooth muscle cells by regulating PPARγ expression and ROS-ERK1/2/p38 signal
[121] Yin X, Gong X, Jiang R, Kuang G, Wang B, Zhang L, et al. Emodin ameliorated
induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways. Eur J
Pharmacol. 2013;705:79-85.
[123] Lee J, Jung E, Lee J, Huh S, Hwang C-H, Lee H-Y, et al. Emodin inhibits TNF alpha-induced
MMP-1 expression through suppression of activator protein-1 (AP-1). Life Sci. 2006;79:2480-5.
[124] Wang R, Wan Q, Zhang Y, Huang F, Yu K, Xu D, et al. Emodin suppresses interleukin-1 beta
induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life
Sci. 2007;80:2481-8.
[125] Li X, Liu W, Wang Q, Liu P, Deng Y, Lan T, et al. Emodin suppresses cell proliferation and
fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol
[126] Ambothi K, Prasad NR, Balupillai A. Ferulic acid inhibits UVB-radiation induced
photocarcinogenesis through modulating inflammatory and apoptotic signaling in Swiss albino mice.
[127] Yang G-W, Jiang J-S, Lu W-Q. Ferulic acid exerts anti-angiogenic and anti-tumor activity by
targeting fibroblast growth factor receptor 1-mediated angiogenesis. Int J Mol Sci. 2015;16:24011-31.
[128] Hou Y, Yang J, Zhao G, Yuan Y. Ferulic acid Inhibits endothelial cell proliferation through NO
[129] Xu T, Pan Z, Dong M, Yu C, Niu Y. Ferulic acid suppresses activation of hepatic stellate cells
through ERK1/2 and Smad signaling pathways in vitro. Biochem Pharmacol. 2015;93:49-58.
38
[130] Wei M-g, Sun W, He W-m, Ni L, Yang Y-y. Ferulic acid attenuates TGF-β1-induced renal cellular
fibrosis in NRK-52E cells by inhibiting Smad/ILK/Snail pathway. Evid Based Complement Alternat
Med. 2015;2015:619720.
[131] Kim H-Y, Lee S-M. Ferulic acid attenuates ischemia/reperfusion-induced hepatocyte apoptosis via
[132] Khan N, Afaq F, Khusro FH, Mustafa AV, Suh Y, Mukhtar H. Dual inhibition of
phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell
[133] Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death
through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis. 2010;31:1424-
33.
[134] Zhang X-J, Jia S-S. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR
[135] Bhat TA, Nambiar D, Pal A, Agarwal R, Singh RP. Fisetin inhibits various attributes of
[136] Park H-H, Lee S, Oh J-M, Lee M-S, Yoon K-H, Park BH, et al. Anti-inflammatory activity of
[137] Kim S-C, Kang S-H, Jeong S-J, Kim S-H, Ko HS, Kim S-H. Inhibition of c-Jun N-terminal kinase
[138] Lee J-D, Huh J-E, Jeon G, Yang H-R, Woo H-S, Choi D-Y, et al. Flavonol-rich RVHxR from Rhus
verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic
factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol.
2009;9:268-76.
39
[139] Kim S-H, Hwang K-A, Choi K-C. Treatment with kaempferol suppressed breast cancer cell growth
caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem.
2016;28:70-82.
[140] Yao S, Wang X, Li C, Zhao T, Jin H, Fang W. Kaempferol inhibits cell proliferation and glycolysis
in esophagus squamous cell carcinoma via targeting EGFR signaling pathway. Tumor Biology.
2016;37:10247-56.
[141] Dang Q, Song W, Xu D, Ma Y, Li F, Zeng J, et al. Kaempferol suppresses bladder cancer tumor
growth by inhibiting cell proliferation and inducing apoptosis. Mol Carcinog. 2015;54:831-40.
[142] Kim S-Y, Jin Y-R, Lim Y, Kim J-H, Cho M-R, Hong J-T, et al. Inhibition of PDGF beta-receptor
tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth
[143] Lee HS, Cho HJ, Kwon GT, Park JHY. Kaempferol downregulates insulin-like growth factor-I
receptor and ErbB3 signaling in HT-29 human colon cancer cells. J Cancer Prev. 2014;19:161–9.
[144] Luo H, Rankin GO, Liu L, Daddysman MK, Jiang B-H, Chen YC. Kaempferol inhibits
angiogenesis and VEGF expression through both HIF dependent and independent pathways in human
[145] Mylonis I, Lakka A, Tsakalof A, Simos G. The dietary flavonoid kaempferol effectively inhibits
HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochem Biophys Res
Commun. 2010;398:74-8.
[146] Luo H, Rankin GO, Juliano N, Jiang B-H, Chen YC. Kaempferol inhibits VEGF expression and in
[147] Chen X, Yang X, Liu T, Guan M, Feng X, Dong W, et al. Kaempferol regulates MAPKs and NF-
κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Int Immunopharmacol.
2012;14:209-16.
40
[148] Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Chaudhary U, et al. Kaempferol attenuates
myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of
[149] Yoon H-Y, Lee E-G, Lee H, Cho IJ, Choi YJ, Sung M-S, et al. Kaempferol inhibits IL-1β-induced
proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
[150] Gong J-H, Cho I-H, Shin D, Han S-Y, Park S-H, Kang Y-H. Inhibition of airway epithelial-to-
mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-
[151] Jin H, Lee WS, Eun SY, Jung JH, Park H-S, Kim G, et al. Morin, a flavonoid from Moraceae,
suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly
[152] Ma Y, Ge A, Zhu W, Liu Y-N, Ji N-F, Zha W-J, et al. Morin attenuates ovalbumin-induced airway
inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid Med Cell Longev.
2016;2016:5843672.
crystal-induced inflammatory immune response in RAW 264.7 macrophages through the inhibition of
inflammatory mediators, intracellular ROS levels and NF-B activation. PloS one. 2015;10:e0145093.
ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by
[155] Li H, Yang B, Huang J, Xiang T, Yin X, Wan J, et al. Naringin inhibits growth potential of human
triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicol Lett. 2013;220:219-
28.
41
[156] Raha S, Yumnam S, Hong GE, Lee HJ, Saralamma VVG, Park H-S, et al. Naringin induces
[157] Zhang Y-S, Li Y, Wang Y, Sun S-Y, Jiang T, Li C, et al. Naringin, a natural dietary compound,
prevents intestinal tumorigenesis in Apc Min/+ mouse model. J Cancer Res Clin Oncol. 2016;142:913-25.
[158] Zeng L, Zhen Y, Chen Y, Zou L, Zhang Y, Hu F, et al. Naringin inhibits growth and induces
[159] Lee E-J, Kim D-I, Kim W-J, Moon S-K. Naringin inhibits matrix metalloproteinase-9 expression
and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Mol Nutr
[160] Chen Y, Nie Y-C, Luo Y-L, Lin F, Zheng Y-F, Cheng G-H, et al. Protective effects of naringin
against paraquat-induced acute lung injury and pulmonary fibrosis in mice. Food Chem Toxicol.
2013;58:133–40.
[161] Chen F, Zhang N, Ma X, Huang T, Shao Y, Wu C, et al. Naringin alleviates diabetic kidney disease
through inhibiting oxidative stress and inflammatory reaction. PloS one. 2015;10:e0143868.
[162] Tsai M-L, Lai C-S, Chang Y-H, Chen W-J, Ho C-T, Pan M-H. Pterostilbene, a natural analogue of
[163] Paul S, Rimando AM, Lee HJ, Ji Y, Reddy BS, Suh N. Anti-inflammatory action of pterostilbene is
mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. Cancer Prev
[164] Paul S, DeCastro AJ, Lee HJ, Smolarek AK, So JY, Simi B, et al. Dietary intake of pterostilbene, a
constituent of blueberries, inhibits the β-catenin/p65 downstream signaling pathway and colon
[165] Chiou Y-S, Tsai M-L, Wang Y-J, Cheng A-C, Lai W-M, Badmaev V, et al. Pterostilbene inhibits
colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal
[166] Pan M-H, Chiou Y-S, Chen W-J, Wang J-M, Badmaev V, Ho C-T. Pterostilbene inhibited tumor
invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
Carcinogenesis. 2009;30:1234-42.
[167] Zhang Y, Zhang Y. Pterostilbene, a novel natural plant conduct, inhibits high fat-induced
atherosclerosis inflammation via NF-κB signaling pathway in Toll-like receptor 5 (TLR5) deficient mice.
[168] Li J, Deng R, Hua X, Zhang L, Lu F, Coursey TG, et al. Blueberry component pterostilbene
protects corneal epithelial cells from inflammation via anti-oxidative pathway. Sci Rep. 2016;6:19408.
[169] Lee MF, Liu ML, Cheng AC, Tsai ML, Ho CT, Liou WS, et al. Pterostilbene inhibits
[170] Singh RP, Gu M, Agarwal R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell
[171] Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R. Inhibitory effect of silibinin against
[172] Raina K, Agarwal C, Agarwal R. Effect of silibinin in human colorectal cancer cells: Targeting the
[173] Kim S, Han J, Kim JS, Kim J-H, Choe J-H, Yang J-H, et al. Silibinin suppresses EGFR ligand-
induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Anticancer Res.
2011;31:3767-73.
[174] Lee M-H, Huang Z, Kim DJ, Kim S-H, Kim MO, Lee S-Y, et al. Direct targeting of MEK1/2 and
RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth. Cancer Prev Res (Phila).
2013;6:455-65.
43
[175] Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW, et al. Silibinin inhibits VEGF secretion
and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR
mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications
[177] Park J-W, Shin N-R, Shin I-S, Kwon O-K, Kim J-S, Oh S-R, et al. Silibinin inhibits neutrophilic
inflammation and mucus secretion induced by cigarette smoke via suppression of ERK‐SP1 Pathway.
[178] Choi YH, Jin GY, Guo HS, Piao HM, chang Li L, Li GZ, et al. Silibinin attenuates allergic airway
[179] Liu W, Li Y, Zheng X, Zhang K, Du Z. Potent inhibitory effect of silibinin from milk thistle on skin
[180] Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C, et al. Silibinin attenuates cardiac hypertrophy
[181] Chen YH, Liang CM, Chen CL, Chen JT, Chang YH, Lu DW, et al. Silibinin inhibits myofibroblast
transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
[182] Cho JW, Il KJ, Lee KS. Downregulation of type I collagen expression in silibinin-treated human
[183] Trappoliere M, Caligiuri A, Schmid M, Bertolani C, Failli P, Vizzutti F, et al. Silybin, a component
of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J
Hepatol. 2009;50:1102-11.
44
[184] Rajput S, Kumar BNP, Dey KK, Pal I, Parekh A, Mandal M. Molecular targeting of Akt by
thymoquinone promotes G 1 arrest through translation inhibition of cyclin D1 and induces apoptosis in
[185] Sutton KM, Greenshields AL, Hoskin DW. Thymoquinone, a bioactive component of black
caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with
[186] Xu D, Ma Y, Zhao B, Li S, Zhang Y, Pan S, et al. Thymoquinone induces G2/M arrest, inactivates
PI3K/Akt and nuclear factorκB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol
Rep. 2014;31:2063-70.
[187] Yang J, Kuang X-r, Lv P-t, Yan X-x. Thymoquinone inhibits proliferation and invasion of human
nonsmall-cell lung cancer cells via ERK pathway. Tumour Biol. 2015;36:259-69.
[188] Yi T, Cho S-G, Yi Z, Pang X, Rodriguez M, Wang Y, et al. Thymoquinone inhibits tumor
angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase
[189] Peng L, Liu A, Shen Y, Xu H-Z, Yang S-Z, Ying X-Z, et al. Antitumor and anti-angiogenesis
effects of thymoquinone on osteosarcoma through the NF-B pathway. Oncol Rep. 2013;29:571-8.
[191] Wang D, Qiao J, Zhao X, Chen T, Guan D. Thymoquinone Inhibits IL-1β-Induced Inflammation in
Inflammation. 2015;38:2235-41.
[192] Umar S, Hedaya O, Singh AK, Ahmed S. Thymoquinone inhibits TNF-α-induced inflammation and
cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Toxicol Appl Pharmacol.
2015;287:299-305.
45
[193] Bai T, Yang Y, Wu Y-L, Jiang S, Lee JJ, Lian L-H, et al. Thymoquinone alleviates thioacetamide-
induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice. Int
Immunopharmacol. 2014;19:351-7.
[194] Bai T, Lian L-H, Wu Y-L, Wan Y, Nan J-X. Thymoquinone attenuates liver fibrosis via PI3K and
TLR4 signaling pathways in activated hepatic stellate cells. Int Immunopharmacol. 2013;15:275-81.
Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation
of pro-fibrotic genes and inhibition of oxidative stress. Environ Toxicol Pharmacol. 2016;45:340-5.
lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor
Figure legends
Fig. 1. Dietary phytochemicals and their chemical structure and dietary sources.
Fig. 2A-B. Smad 2/3 (A) and PI3K (B) signaling pathways in uterine leiomyoma targeted by dietary
phytochemicals.
Fig. 3A-B. ERK 2/3 (A) and β-catenin (B) signaling pathways in uterine leiomyoma targeted by dietary
phytochemicals.
47
Figure 1
48
Figure 2
49
Figure 3